The fact that insulin sensitizers, and not antiandrogens, are the more effective treatment of PCOS suggests that insulin sensitivity might be at the core of the disorder; though it is important to note that not all patients have reduced insulin sensitivity. This evidence concerns the gene INS and polycystic ovary syndrome.